Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01734928. IPD Sharing: Not stated. Countries: 22. Publications: 2.
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT00006184. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00920855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT00722566. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00098475. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02078102. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00603447. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00644228. IPD Sharing: Not stated. Countries: 3. Publications: 4.
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma
ClinicalTrials.gov study NCT03602612. IPD Sharing: YES. Countries: 1. Publications: 0.
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01212952. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01023308. IPD Sharing: Not stated. Countries: 34. Publications: 4.
Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01712789. IPD Sharing: Not stated. Countries: 20. Publications: 4.
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
ClinicalTrials.gov study NCT00427765. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01239797. IPD Sharing: Not stated. Countries: 23. Publications: 3.
Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients
ClinicalTrials.gov study NCT00507442. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
ClinicalTrials.gov study NCT00322491. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
ClinicalTrials.gov study NCT00075829. IPD Sharing: YES. Countries: 1. Publications: 3.
TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)
ClinicalTrials.gov study NCT02043847. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03361748. IPD Sharing: Not stated. Countries: 8. Publications: 10.
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00511238. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.